Cargando…
Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogenic Hematopoietic Cell Transplantation
Autores principales: | Henmi, Heisuke, Imamura, Teruhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037008/ https://www.ncbi.nlm.nih.gov/pubmed/35871598 http://dx.doi.org/10.2169/internalmedicine.9818-22 |
Ejemplares similares
-
Response to: Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogeneic Hematopoietic Cell Transplantation
por: Yanagiya, Ryo, et al.
Publicado: (2022) -
Clinical Implication of Ivabradine Administration Before Non-Cardiac Surgery
por: Imamura, Teruhiko
Publicado: (2021) -
Comment on: Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: Rationale and design of SHIFT‐AHF trial
por: Imamura, Teruhiko, et al.
Publicado: (2021) -
Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure
por: Hori, Masakazu, et al.
Publicado: (2020) -
Ivabradine as an Adjuvant Agent for Severe Heart Failure Occurring in the Early Phase after Allogeneic Hematopoietic Cell Transplantation
por: Yanagiya, Ryo, et al.
Publicado: (2022)